A simple measurement of abdominal obesity

September 27, 2018

In obesity research, the body mass index (BMI) has been traditionally used to determine if an individual is normal weight, underweight, overweight or obese. However, BMI does not differentiate between the types of the mass (fat or muscle) or body shapes. Given that increased abdominal fat content specifically has been associated with increased risks of cardiovascular diseases and mortality rate, waist-to-hip (WHR) ratio is widely used by researchers to highlight abdominal fat content associated with obesity. However, WHR underestimates obesity for '"pear shaped'" body types and overestimates it for '"apple shaped'" body types. Thus, both BMI and WHR do not specifically measure central obesity or are not precise for certain body types.

A research team lead by Zhiyong Han, Ph.D. at the Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey has published a new report in the Open Journal of Nutrition on July 2018 that describes an elegant, simple way of measuring abdominal obesity index (ABOI) to determine central obesity of individuals.

On the importance of the findings, Dr. Han says, id: "The advantage of ABOI is in its simplicity and its focus on abdominal fat regardless of the total body weight, body shape and body height. ABOI can be easily calculated by measuring abdominal circumference and chest circumference. In using this approach, we were able to use ABOI to focus on abdominal obesity."

In the report, the authors also show that combinatorial use of ABOI and waist to height ratio (WHtR) appears to provide another approach to index patients into clinical subgroups. "The clinical usefulness of ABOI remains to be tested. We plan on conducting studies to use ABOI and WHtR to assess an individual's risks for cardiovascular diseases, diabetes and dyslipidemia" said Dr. Han.
For more information about this article, please visit https://benthamopen.com/ABSTRACT/TONUTRJ-12-21

Reference: Amankwah N., (2018). Abdominal Obesity Index as an Alternative Central Obesity Measurement During a Physical Examination. The Open Nutrition Journal, 2018. DOI: 10.2174/1874288201812010021

Bentham Science Publishers

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.